Copenhagen, Denmark; January 29, 2014 – Genmab A/S (OMX: GEN) announce under reference to Section 29 of the Danish Securities Trading Act that Johnson & Johnson Development Corporation (JJDC) has informed us that as of January 29, 2014 their total shareholding in Genmab A/S after the execution of the capital increase in Genmab A/S, executed on January 29, 2014, consists of 5,400,000 shares corresponding to 9.58% of the share capital and voting rights in Genmab A/S.
Help employers find you! Check out all the jobs and post your resume.
